PFA

SHR EE G AN ESH BI O - T E C H (I ND I A) L I M I TED CIN: L70101WB1982PLC121196 Reg. Office: CUBICLE NO.: 126, 3/2, 75C, PARK STREET, 3RD FLOOR, KAMDHENU BUILDING, KOLKATA -700016 Email: shreeganeshbiotechindialtd@gmail.com Website: www.shreeganeshbiotech.shop Date: 04.08.2026 To, To, To, Listing Department, The Secretary, Head - Listing BSE Limited, The Calcutta Stock Metropolitan Stock Exchange P J Tower, Dalal Exchange Ltd, of India Limited Street 7, Lyons Range, Vibgyor Towers, 4th floor, Plot Mumbai-400001 Kolkata - 700001 No C 62, Opp. Trident Hotel Bandra Kurla Complex, Bandra (E), Mumbai – 400098 Scrip Code: 539470 Scrip Code: 29221 Scrip Code: SHREEGANES Dear Sir/Madam, Sub: Disclosure under Regulation 32(1) of SEBI (listing Obligation and Disclosure Requirements) Regulations, 2015 Pursuant to SEBI Circular - CIR/CFD/CMD1/162/2019 dated 24th December, 2019 regarding statement on Deviation or variation for proceeds of public issue/Rights Issue/preferential issue, Qualified institutional placement (QIP) etc., read with Regulation 32(1) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we would like to inform that: The Company does not have any funds remaining unutilised as on 30th June 2026, or as on date, out of the proceeds of public issue/Rights Issue/preferential issue, qualified institutional placement (QIP) etc., if any undertaken by it at anytime in the past. In view of the aforesaid, no information is being provided by way of Annexure-A pursuant to the said Regulation / Circular. This is for your information and records. Thanking You. Yours faithfully FOR, SHREE GANESH BIOTECH (INDIA) LIMITED Aman Patel Wholetime Director